New Delhi: ITI Ltd stock is buzzing after it was announced that it and domestic AI company Thalamus Irwine will jointly bid on healthcare projects.
ITI and Thalamus Irvine announced that they will apply for health projects such as the National Digital Health Mission to provide artificial intelligence solutions for the digital health record system.
With the rising second wave of Covid-19 in India and the growing need for a Covid and Health Passport system, ITI Ltd, a government power supply under the Ministry of Communications, and Thalamus Irwine, a Delhi-based AI company, under his The Health Platform Garuda has demonstrated a working Proof of Concept (PoC) for the technology that can accelerate Prime Minister Narendra Modi’s rollout of the One Nation, One Health Card vision.
Rakesh Mohan Agarwal, Chairman and CEO of ITI Ltd, said, “ITI’s partnership with Garuda enables us to bring blockchain technology to the forefront of the healthcare ecosystem. The very first PoC of these AI-based tests was conducted in Bangalore and another was carried out in Delhi Airport under the Garuda brand. With this initiative, we are one step ahead of block-chain technology for secure storage of data. To ensure data security, ITI has already set up a Tier 3 data center , which stores all information. Citizens’ health cards can be safely stored. This is the first of its kind to help build a robust healthcare ecosystem. With this unique collaboration, ITI will be one of the first power supplies to bring medical data into a blockchain network. ”
ITI Ltd is the country’s leading telecommunications company and the multi-entity central public sector company is a total solution provider in the telecommunications segment
On March 26th, ITI stock closed at Rs 115.65, up Rs 2.35, or 2.07 percent, from its previous close of Rs. 113.30 on the BSE.
The scrip opened at Rs 114.00 and has hit high and low of Rs 117.50 and Rs 114.00 respectively.
ITI stock hit a 52-week high of Rs 151.60 on August 19, 2020 and a 52-week low of Rs 50.25 on March 26, 2020.